Mary Fisher is of Dermata Therapeutics, Inc.. Currently has a direct ownership of 196,946 shares of DRMA, which is worth approximately $238,304. The most recent transaction as insider was on Jan 21, 2025, when has been sold 196,851 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 197K
740.11% 3M change
740.11% 12M change
Total Value Held $238,304

MARY FISHER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2025
BUY
Grant, award, or other acquisition
-
196,851 Added 49.99%
196,946 Common Stock
Oct 06 2022
BUY
Grant, award, or other acquisition
-
9,810 Added 29.5%
23,443 Common Stock
Jul 07 2022
BUY
Grant, award, or other acquisition
-
8,602 Added 38.69%
13,633 Common Stock
Apr 07 2022
BUY
Grant, award, or other acquisition
-
5,031 Added 50.0%
5,031 Common Stock

Also insider at

SIEN
Sientra, Inc. Healthcare
MF

Mary Fisher

San Diego, CA

Track Institutional and Insider Activities on DRMA

Follow Dermata Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DRMA shares.

Notify only if

Insider Trading

Get notified when an Dermata Therapeutics, Inc. insider buys or sells DRMA shares.

Notify only if

News

Receive news related to Dermata Therapeutics, Inc.

Track Activities on DRMA